Dacisteine Inhibitor

Dacisteine is a cysteine derivative. It displays a less New Delhi metallo-beta-lactamase-1 (NDM-1) inhibitor (IC50: 1000uM). Dacisteine can be used for the treatment,of cardiovascular and cerebrovascular diseases caused by platelet aggregation.

Cui-Gai Bai1, et al. Cysteine and Its Derivatives as New Delhi Metallo-beta-lactamase-1 Inhibitors. Current Enzyme Inhibition, 2015, 11, 46-57
Cui-Gai Bai1, et al. Cysteine and Its Derivatives as New Delhi Metallo-beta-lactamase-1 Inhibitors. Current Enzyme Inhibition, 2015, 11, 46-57
FanKe, et al. Application of compound of thioether acid structure in preparing anti-platelet aggregation drugs. Patent WO2019007015A1.
FanKe, et al. Application of compound of thioether acid structure in preparing anti-platelet aggregation drugs. Patent WO2019007015A1.

Small volumes of Dacisteine, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5754765 is an inhibitor targeting Dacisteine.